These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Role of Probiotics in the Prevention of Dudzicz-Gojowy S; Więcek A; Adamczak M Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474799 [TBL] [Abstract][Full Text] [Related]
3. The role of the gut microbiome in colonization resistance and recurrent Seekatz AM; Safdar N; Khanna S Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405 [TBL] [Abstract][Full Text] [Related]
4. Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review. Mihaescu A; Augustine AM; Khokhar HT; Zafran M; Masood SSME; Gilca-Blanariu GE; Covic A; Nistor I Biomed Res Int; 2021; 2021():5466656. PubMed ID: 34557546 [No Abstract] [Full Text] [Related]
5. A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection. Bhute SS; Mefferd CC; Phan JR; Ahmed M; Fox-King AE; Alarcia S; Villarama JV; Abel-Santos E; Hedlund BP Microbiol Spectr; 2022 Aug; 10(4):e0180421. PubMed ID: 35708337 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection. Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379 [TBL] [Abstract][Full Text] [Related]
10. Is Increased BMI a Risk Factor for Developing Severe Clostridioides Difficile Infection? A Retrospective Study. Chatterjee T; Bansal S; Abuzar A; Hussain H; Gupta L J Community Hosp Intern Med Perspect; 2022; 12(6):43-50. PubMed ID: 36816160 [TBL] [Abstract][Full Text] [Related]
11. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection. Kim SC; Seo MY; Lee JY; Kim KT; Cho E; Kim MG; Jo SK; Cho WY; Kim HK Korean J Intern Med; 2016 Jan; 31(1):125-33. PubMed ID: 26767866 [TBL] [Abstract][Full Text] [Related]
12. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. Finn E; Andersson FL; Madin-Warburton M BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040 [TBL] [Abstract][Full Text] [Related]
13. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience. Pipek B; Valentová H; Fojtík P; Urban O Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450 [TBL] [Abstract][Full Text] [Related]
15. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection. Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K mBio; 2020 May; 11(3):. PubMed ID: 32371595 [No Abstract] [Full Text] [Related]
16. Hospital acquired Clostridioides difficile infection and risk factors for severity in a university hospital: A prospective study. Bilgin H; Sayın E; Gürün HP; Tükenmez-Tigen E; Ülger Toprak N; Korten V Am J Infect Control; 2020 Dec; 48(12):1426-1430. PubMed ID: 32522607 [TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. Thongprayoon C; Cheungpasitporn W; Phatharacharukul P; Edmonds PJ; Kaewpoowat Q; Mahaparn P; Bruminhent J; Erickson SB Int J Clin Pract; 2015 Sep; 69(9):998-1006. PubMed ID: 26147121 [TBL] [Abstract][Full Text] [Related]